Dentsply Sirona XRAY

Dentsply Sirona has faced ongoing financial turmoil, culminating in significant shifts in leadership and strategic direction. Following a series of disappointing earnings reports, including a Q4 2022 net loss of $146 million and a 39% year-over-year decline in adjusted earnings per share, the company announced a restructuring plan aimed at saving $120 million annually. Despite recent improvements in sales, Dentsply's stock has struggled, dropping steadily and leading to a suspension of dividends to focus on debt reduction. As it attempts a 'Return to Growth' strategy amid competitive pressures and operational losses, investor confidence remains low, with analysts casting doubt on the company's long-term viability.